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Abstract
Background: We describe how we used the framework of the U.S. Department of Veterans Affairs (VA) Quality Enhancement
Research Initiative (QUERI) to develop a program to improve rates of diagnostic testing for the Human Immunodeficiency Virus
(HIV). This venture was prompted by the observation by the CDC that 25% of HIV-infected patients do not know their diagnosis
– a point of substantial importance to the VA, which is the largest provider of HIV care in the United States.
Methods: Following the QUERI steps (or process), we evaluated: 1) whether undiagnosed HIV infection is a high-risk, high-
volume clinical issue within the VA, 2) whether there are evidence-based recommendations for HIV testing, 3) whether there
are gaps in the performance of VA HIV testing, and 4) the barriers and facilitators to improving current practice in the VA.
Based on our findings, we developed and initiated a QUERI step 4/phase 1 pilot project using the precepts of the Chronic Care
Model. Our improvement strategy relies upon electronic clinical reminders to provide decision support; audit/feedback as a clinical
information system, and appropriate changes in delivery system design. These activities are complemented by academic detailing
and social marketing interventions to achieve provider activation.
Results: Our preliminary formative evaluation indicates the need to ensure leadership and team buy-in, address facility-specific
barriers, refine the reminder, and address factors that contribute to inter-clinic variances in HIV testing rates. Preliminary
unadjusted data from the first seven months of our program show 3–5 fold increases in the proportion of at-risk patients who
are offered HIV testing at the VA sites (stations) where the pilot project has been undertaken; no change was seen at control
stations.
Discussion: This project demonstrates the early success of the application of the QUERI process to the development of a
program to improve HIV testing rates. Preliminary unadjusted results show that the coordinated use of audit/feedback, provider
activation, and organizational change can increase HIV testing rates for at-risk patients. We are refining our program prior to
extending our work to a small-scale, multi-site evaluation (QUERI step 4/phase 2). We also plan to evaluate the durability/
sustainability of the intervention effect, the costs of HIV testing, and the number of newly identified HIV-infected patients.
Ultimately, we will evaluate this program in other geographically dispersed stations (QUERI step 4/phases 3 and 4).
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Background
Over the past decade, in the developed world, the Human
Immunodeficiency Virus (HIV) has been transformed
from a fatal disease with rapid progression to clinical
AIDS (Acquired Immune Deficiency Syndrome) and
death – to a chronic illness that can be successfully man-
aged through outpatient-based care over long periods of
active life. However, advances in the effectiveness of treat-
ment have been accompanied by new challenges for
healthcare systems as they aim to provide adequate
chronic illness care to large numbers of ambulatory HIV
patients.
Unfortunately, the Centers for Disease Control and Pre-
vention (CDC) estimates that approximately 25% of the
nearly one million HIV-infected persons in the United
States are not aware of their status [1]. Thus one of the key
barriers to the receipt of care for HIV infection is under-
diagnosis of this condition, particularly in the early,
asymptomatic phases of illness when medical interven-
tion is highly cost-effective [2,3]. This article is one in a
Series  of articles documenting implementation science
frameworks and approaches developed by the U.S.
Department of Veterans Affairs (VA) Quality Enhance-
ment Research Initiative (QUERI). QUERI is briefly out-
lined in Table 1 and is described in more detail in
previous publications [4,5]. The QUERI Series' introduc-
tory article [6] highlights aspects of QUERI related specif-
ically to implementation science, and describes additional
types of articles contained in the Series.
The specific QUERI Centers are the operational arm of
QUERI. Their establishment is determined by VA's Health
Services Research and Development Service (HSR&D), in
conjunction with clinical management. The existence of
the HIV/Hepatitis QUERI Center, in part, reflects the fact
that the VA is the largest single provider of HIV care in the
United States, providing care for more than 20,000 veter-
ans with HIV, or roughly 40% of the nation's HIV-infected
veteran population [1,7]. The original mission of the HIV/
Hepatitis QUERI Center was to increase access to, and
uptake of, evidence-based HIV care, and to improve the
care that veterans receive for their disease and associated
comorbid diseases. More recently, the scope of this Center
has expanded to include veterans with chronic viral hepa-
titis.
Previous accomplishments of the HIV/Hepatitis QUERI
Center include the development of effective decision sup-
port tools for HIV providers; analyses of the cardiovascu-
lar and cerebrovascular risk from long-term, highly-active
antiretroviral therapy; determination of the scientific
rational for early identification of HIV infection; develop-
ment and assessment of strategies to improve medication
adherence; and validation of the utility of rapid tests for
diagnosis of HIV infection in the VA [8-13].
The purpose of this paper is to provide an illustrative case
study that demonstrates work done by the HIV/Hepatitis
QUERI Center, and to apply the QUERI 6-step/4-phase
framework to the development and implementation of a
Table 1: The VA Quality Enhancement Research Initiative (QUERI)
The U.S. Department of Veterans Affairs' (VA) Quality Enhancement Research Initiative (QUERI) was launched in 1998. QUERI was designed to 
harness VA's health services research expertise and resources in an ongoing system-wide effort to improve the performance of the VA healthcare 
system and, thus, quality of care for veterans.
QUERI researchers collaborate with VA policy and practice leaders, clinicians, and operations staff to implement appropriate evidence-based 
practices into routine clinical care. They work within distinct disease- or condition-specific QUERI Centers and utilize a standard six-step process:
1) Identify high-risk/high-volume diseases or problems.
2) Identify best practices.
3) Define existing practice patterns and outcomes across the VA and current variation from best practices.
4) Identify and implement interventions to promote best practices.
5) Document that best practices improve outcomes.
6) Document that outcomes are associated with improved health-related quality of life.
Within Step 4, QUERI implementation efforts generally follow a sequence of four phases to enable the refinement and spread of effective and 
sustainable implementation programs across multiple VA medical centers and clinics. The phases include:
1) Single site pilot,
2) Small scale, multi-site implementation trial,
3) Large scale, multi-region implementation trial, and
4) System-wide rollout.
Researchers employ additional QUERI frameworks and tools, as highlighted in this Series, to enhance achievement of each project's quality 
improvement and implementation science goals.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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program to improve rates of HIV diagnostic testing in VA
medical care facilities.
The key issues addressed in this paper focus on how the
QUERI framework guided our efforts to: 1) identify spe-
cific gaps in care, barriers to diagnosis, and the loci within
the VA where interventions to improve HIV diagnostic
testing would have the greatest impact; 2) develop an
intervention to improve diagnostic testing; and 3) imple-
ment a staged-series of studies to evaluate the effectiveness
of this program. We also discuss how we used known
quality improvement strategies to change the behavior of
primary care providers in regard to HIV testing.
In the following sections, we show how Steps 1–3 of the
QUERI process were followed to demonstrate that undi-
agnosed HIV infection is a high-risk, high-volume clinical
issue (QUERI step 1), that there are evidence-based rec-
ommendations for HIV testing (QUERI step 2), and that
there are gaps in the performance of HIV testing within
the VA healthcare system (QUERI step 3).
Based on this foundation, and with the support of theo-
retical and empirical considerations, we have developed
and initiated a two-site (station) pilot project (QUERI
step 4/phase 1) with the goal of refining our interventions
to improve rates of HIV testing prior to launching a small-
scale, multi-site evaluation in 5 separate stations (QUERI
step 4/phase 2).
Methods
Step 1: Priority Condition/Issue: Is undiagnosed HIV 
infection a high-risk, high-volume clinical issue within the 
VA?
The observation by the CDC that 25% of HIV-infected
patients in the United States do not know their status is of
great relevance to the VA [1] because the VA treats more
than 20,000 veterans with HIV per year [1]. If, as in the
rest of the country, 25% of HIV-infected VA patients do
not know their status, approximately 7,000 veterans are at
risk of being diagnosed with HIV and treated only when
they become symptomatic and severely immunosup-
pressed. Thus, since HIV patients benefit greatly from
early diagnosis and treatment [2,3], increased HIV testing
in the VA can substantially reduce the number of newly
diagnosed veterans who present with concurrent compli-
cations of profound immunodeficiency [3,14] and extend
survival for the average HIV-infected patient by 1.5 years
[2,3].
The decision by the HIV/Hepatitis QUERI Center to focus
on HIV testing as a priority within HIV quality improve-
ment was based on the above observations. This decision
was approved by the nationally constituted executive
committee of the HIV/Hepatitis QUERI Center. QUERI
processes require that this prioritization needs to be re-
justified on an annual basis through the development of
a strategic plan that is reviewed and approved by VA/
HSR&D Central Office appointees, representing both
researchers and clinical management.
Step 2: Evidence-based Practices: Are there evidence-
based recommendations for HIV testing?
The U.S. Preventive Services Task Force (USPSTF) gives a
Grade A recommendation to HIV screening for all adoles-
cents and adults who are at increased risk for HIV infec-
tion or who receive health care in a high-prevalence
setting, such as where ≥ 1% of the patient population is
known to be HIV-infected (Table 2) [15]. The VA has
endorsed the USPSTF guidelines for HIV infection and has
identified testing for HIV as being a high priority [16].
The cost-effectiveness of HIV testing in the VA is well
established. As shown by a HIV/Hepatitis QUERI-affili-
ated investigator and others, for a population with a prev-
alence of HIV infection of ≥ 1%, the cost of one-time
screening for HIV infection is $15,078 per quality-
adjusted life-year gained [2]. Analyses that consider the
relationship of diagnosis and treatment on HIV transmis-
sion show that the cost of routine HIV screening is <
$50,000 per quality-adjusted life-year gained, unless the
prevalence of HIV infection is <0.05% [2]. This level of
cost effectiveness, which matches that of many well-
accepted procedures such as performing colonoscopy for
colorectal screening [17], provides a strong argument in
favor of implementing HIV testing programs, especially as
VA patients have rates of HIV much higher than the 0.05%
lower bound of cost-effectiveness [18].
Step 3: Quality/Performance Gaps: Are there gaps in the 
performance of HIV testing in the VA?
Previous studies done by HIV/Hepatitis QUERI, the VA
Public Health Strategic Healthcare Group (PHSHG, a ded-
icated national VA program office for guiding HIV care
services), and other VA groups have shown that only 30 –
50% of VA patients with known, documented risk factors
have undergone HIV testing [11,16]. Furthermore, at the
time of HIV diagnosis half of the veterans have advanced
levels of immune suppression. These veterans have, on
average, 3.7 years of VA care before their HIV is diagnosed
[19].
To confirm and extend these data, we evaluated the rates
of HIV testing in veterans seen in the five southern Cali-
fornia and Nevada VA facilities (otherwise referred to as
Veterans Integrated Service Network 22 or VISN 22). We
found that between January 1999 and December 2004
only 30% of the 45,776 at-risk veterans (i.e., VA patients
with positive laboratory tests or diagnostic codes for hep-
atitis, sexually transmitted diseases, and/or substanceImplementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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abuse) had been tested for HIV infection. The rate of test-
ing for at-risk patients ranged from a low of 8% in primary
care clinics to a high of 47% in substance abuse clinics.
The low testing rates and large number of at-risk veterans
in VA primary care clinics (nearly ten times as great as in
substance use clinics due to the vast differences in the size
of these clinic populations) pointed to the need for an
intervention to focus on improvements in HIV testing per-
formance in VA primary care clinics. To better understand
the source of gaps in care and to discern facilitators that
would improve current practice, we reviewed VA policies
regarding HIV testing and surveyed providers' practices
and attitudes regarding HIV testing at two VA facilities.
Following, we present these findings.
Organizational factors
Public Law 100–322 requires that VA patients provide vol-
untary informed consent for HIV testing and that provid-
ers document pre- and post-test counseling [16]. In
addition, many VA providers regard HIV testing and pre-
and post-counseling to be the sole provenance of specially
trained HIV counselors [20]. Furthermore, standard pol-
icy has been to require all patients with positive or nega-
tive test results to come back to clinic for face-to-face,
post-test counseling. The post-test counseling appoint-
ment is problematic, as many VA providers do not have
sufficient appointment slots to allow for timely in-person
patient notification of test results (i.e., within 1–2 weeks
of the test).
Provider willingness and ability to perform HIV testing
Surveys of a convenience sample of 30 VA primary care
providers indicated that lack of knowledge of individuals'
risk factors for HIV infection, the time requirements to ful-
fill necessary counseling processes [20,21], and anxiety
about post-test counseling patients who have positive test
results [14,22] were substantive barriers to ordering HIV
tests.
Patient acceptance of HIV testing
A systematic review of 62 studies found that acceptance
rates of voluntary HIV testing in the United Sates varies
from 11% to 91% [23]. Importantly, this review found
that higher acceptance rates were associated with confi-
dentiality protections (strongly upheld by VA policy and
procedures), as well as the provider's belief that testing
would be beneficial.
Step 4: Identify and implement interventions to promote 
best practices
Here we describe our QUERI step 4 activities in further
detail. We are now nearing the end of phase 1 of step 4,
wherein we are conducting a two-station (two-site) pilot
project.
Table 2: US Preventive Services Task Force Grade A Recommendations for HIV Screening*
Clinicians should screen for HIV all adolescents and adults at increased risk for HIV.
A person is considered at increased risk for HIV infection if he or she reports one or more individual risk factors or receives health care in a high-
prevalence or high-risk clinical setting. HIV Risk factors include:
• Men who have had sex with men after 1975.
• Men and women having unprotected sex with multiple partners.
• Past or present injection drug users.
• Men and women who exchange sex for money or drugs or have sex partners who do.
• Individuals whose past or present sex partners were HIV-infected, bisexual, or injection drug users.
• Persons being treated for sexually transmitted diseases (STDs).
• Persons with a history of blood transfusion between 1978 and 1985.
• Persons who request an HIV test despite reporting no individual risk factors.
High-risk clinical settings:
• STD clinics,
• Correctional facilities,
• Homeless shelters,
• Tuberculosis clinics,
• Clinics serving men who have sex with men, and
• Adolescent health clinics with a high prevalence of STDs.
High-prevalence settings:
• High-prevalence settings are defined by the CDC as those known to have a 1% or greater prevalence of infection among the patient population 
being served.
Clinicians should screen all pregnant women for HIV
*As defined by the US Preventive Services Task Force, screening means counseling and testing.
Adapted from [15]Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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Collaborating with clinical services to design an 
appropriate intervention
We explicitly sought broad institutional support for this
project. This included the support of the VA PHSHG, and
the VISN 22 Director, Quality Improvement Council,
Clinical Practices Council, and the Clinical Performance
Committee. VISN 22 leadership agreed to make HIV test-
ing a performance monitor, to support installation of the
HIV Testing Clinical Reminder, and to participate as full
partners in enhancing station accountability. After obtain-
ing national and regional support, we also made presen-
tations to, and received support from the Medical
Executive Committees, Chiefs of Staff, Ambulatory Care
Leadership, primary care teams, and the HIV Coordina-
tors at our two intervention stations. Receipt of all this
support was greatly facilitated by the products generated
from QUERI steps 1–3.
Development and initiation of a program to improve rates 
of HIV testing
Conceptual basis of the implementation interventions
As required by the QUERI process, we paid careful atten-
tion to the selection of a quality improvement model
upon which to base our intervention program. We elected
to base our program upon the Chronic Care Model (CCM).
This decision was based on the previous, wide success of
interventions based on the CCM precepts to improve clin-
ical preventive care services [24,25]. Further guidance for
this implementation strategy was provided by Rogers,
whose germinal work on diffusion promotes the use of
opinion leaders or champions to facilitate change or inno-
vation adoption, and highlights the importance of indi-
viduals' social networks, organizational leadership and
structure [26].
Key components of the CCM include a clear definition of
optimal care and enumeration of targeted patients, i.e.,
offering HIV-testing to at-risk patients; a road map for
changing the system; and an effective improvement strat-
egy [27]. Effective CCM implementation strategies also
contain the following elements: decision support, clinical
information systems, delivery system design, and patient
self management [24,28-30]. Therefore, we developed an
implementation strategy that uses: clinical reminders to
provide decision support, audit/feedback as a clinical infor-
mation system, and organizational change to achieve an
appropriate delivery system design. These activities are com-
plemented by academic-detailing and social marketing
interventions to achieve provider activation to ensure that
providers have the skills and motivation to improve their
performance [24,29-31]. Both the CCM and the Institute
for Healthcare Improvements Breakthrough Series have
identified the need for provider activities to transform and
sustain changes in group norms [24,29,30]. Thus, we
chose to implement a multi-faceted provider activation
program that includes academic detailing and social market-
ing [25]. Finally, we promoted HIV counseling to increase
patient self-management by wide scale publicity of the HIV
testing program in clinic waiting rooms and check-in
areas.
Table 3 summarizes the relationships between the barriers
to HIV testing, the content of the planned implementa-
tion program, and the relationship of each intervention to
the elements of our CCM-based implementation strategy,
which was augmented by academic-detailing and social-
marketing interventions (provider activation). In the fol-
lowing section, we discuss the components of these inter-
ventions and the methods of delivery in more detail.
Components of the implementation program
Decision Support
To leverage institutional resources, we implemented a
real-time, electronic clinical reminder that had been
Table 3: Relationship between Identified Barriers, Elements of the Chronic Care Model and Implementation Strategy
Barrier to HIV testing Content of implementation intervention Relationship to Chronic Care Model*
Lack of knowledge of HIV risk factors. HIV Testing Clinical Reminder Decision support
VA providers regard HIV testing and counseling 
work to be the responsibility of specially trained HIV 
counselors.
Audit/feedback reports
Training to use revised VA HIV Consent Form
Academic detailing, social marketing
Clinical information system
Delivery system design
Provider activation
Lack time required to fulfill counseling processes. Provider training regarding streamlined 
counseling
Nurse-based pre-test counseling
Academic detailing, social marketing
Delivery system design
Provider activation
Face-to-face post-test counseling is difficult to 
arrange within two weeks of the test.
Telephonic notification of negative test results.
Academic detailing, social marketing
Delivery system design
Provider activation
Anxiety about post-test counseling for positive test 
results.
Assistance provided by HIV counseling 
services.
Academic detailing, social marketing
Delivery system design
Provider activation
• Provider activation is not, strictly speaking, a component of the CCM based implementation strategy, but was rather employed to augment the 
effectiveness of the other interventions [24;29;30].Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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developed by the VA PHSHG to identify veterans at higher
than average risk for HIV infection – and to encourage
providers to offer HIV testing to such individuals (Figure
1). Widely used to implement quality improvement, clin-
ical reminders are well-suited for use in the VA because of
the system-wide computerized patient record. The HIV
Testing Clinical Reminder is triggered by prior evidence of
infection by Hepatitis B or C infection, illicit drug use, sex-
ually transmitted diseases (STDs), homelessness, and/or
documented risk factors for Hepatitis C infection. All
these data elements can be automatically extracted from
the VA electronic medical record. The reminder is resolved
(i.e., appropriately addressed) by: ordering an HIV test,
recording the result of an HIV test performed elsewhere,
indicating that the patient is not competent to consent to
testing, or specifying that the patient refuses HIV testing.
Once resolved, the reminder is no longer triggered.
The use of clinical reminders in individual patients, when
combined with audit/feedback and organizational
changes, has been shown to improve performance of vac-
cination, cardiovascular risk reduction, and breast and
colorectal cancer screenings [9,10,28,31-33]. Electronic
clinical reminders are a standard well-developed technol-
ogy with which VA providers have great familiarity and
have been shown to be well suited to improve perform-
The HIV Testing Clinical Reminder is activated whenever a patient with HIV risk factors, who has not been previously tested  for HIV, has an encounter with a healthcare provider Figure 1
The HIV Testing Clinical Reminder is activated whenever a patient with HIV risk factors, who has not been previously tested 
for HIV, has an encounter with a healthcare provider. The format of the Reminder is as pictured.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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ance of tasks similar in nature to HIV test ordering and
counseling. Furthermore, our previous work has shown
that use of clinical reminders contributes to 10–30%
increases in the rates of appropriate clinical interventions
in VA HIV-infected patients [9,10]. Thus, this implemen-
tation intervention satisfies the FITT (fit between individ-
uals, task and technology) framework for assessing the
suitability of using this intervention in our strategy [34].
Clinical information system
We designed an audit-feedback system, wherein health-
care providers are informed of group performance in
regard to HIV screening rates in at-risk patients. A meta-
analysis of 85 trials demonstrates that the use of audit-
feedback is effective in improving practice, especially
when baseline adherence is low [35]. We have distributed
audit-feedback reports (Figure 2) to senior medical center-
level clinical managers, outpatient clinic managers, and
primary care team leaders at the Los Angeles and the San
Diego VA stations. The contents of the reports have been
discussed during academic detailing visits to primary care
team meetings, and in the social marketing campaign.
Informal provider feedback regarding the content of these
reports has been positive.
Provider activation
We implemented a provider activation program that
includes academic detailing and social marketing
[25,35,36]. This approach recognizes that the engagement
of providers and the use of multiple modalities are neces-
sary to achieve and sustain the transformation of group
norms and maximize quality improvement
[24,25,29,30,35]. The goal of these activities was to
engage providers and influence their attitudes, skills and
habits regarding offering HIV testing to at-risk patients.
We also used these interactions to reinforce more formal
educational efforts. Particular attention was paid to:
increasing providers' sense of responsibility for ordering
HIV tests, emphasizing the use of streamlined pre-test
counseling, reinforcing the use of telephonic notification
of negative test results, and assuring providers of the avail-
ability of assistance for notification of persons with posi-
tive test results.
The academic detailing component of the project involves
multiple presentations by clinical champions (physician
and nursing staff), supplemented by project staff to the
primary care team meetings and educational sessions. We
have specifically targeted primary care clinic leaders as
local, organizational opinion leaders [25]. We used social
marketing with providers to reinforce the importance of
changing their practice regarding HIV testing, and further
motivate them to do so. Social marketing entails the
development of a shared buy-in to the overall goal of the
behavior change and is predicated on social exchange the-
ory, which borrows from social and behavioral science
doctrines in emphasizing the client/patient/provider as
the starting point [37]. The social marketing element
includes regular informal discussions of the basis for and
benefits of increased rates of HIV testing by project staff
during frequent ad hoc visits to the primary care clinic and
presentations to sub-station and clinic leadership.
As per the precepts of social marketing theory [37], we
have undertaken: audience segmentation for focused detail-
ing to nurses, mid-level providers and physicians; channel
analysis  to optimize the setting and materials for these
audience segments; goal orientation to keep stakeholders
focused on why they are involved (i.e., emphasizing the
differing tasks by nurses [pre-test counseling ] and physi-
cians [order entry]); and process tracking to monitor
progress and provide feedback for refinement and revi-
sion of strategies (i.e., through audit-feedback and
through formative evaluation), which can be considered
an intervention [38].
Based on survey responses by physicians, mid-level pro-
viders, nurses, and case managers, we also have developed
provider education materials to supplement the face-to-
face training conducted by project staff that focus on pre-
paring providers to use the reminders effectively, making
providers aware of HIV risk factors not captured by the
reminder (i.e., multiple unprotected sexual contacts), and
increasing provider comfort and abilities to provide pre-
and post-test HIV counseling.
In our step 4/phase 1 project, all social marketing has
been performed by senior project staff. Using the insights
gained in the two-station pilot project, as we progress
down the pipeline to a step 4/phase 2 small-scale, multi-
station evaluation we will rely on a train-the-trainer
model to activate local champions. Project staff will sup-
port the local champions with regular visits (monthly for
the first 3 months of local implementation, and then
quarterly), weekly telephone conference calls and e-mail
support.
Delivery System Changes
We have strived to ensure that all providers are trained to
use a recent revision of the VA HIV Consent Form [39].
This new document includes all the necessary elements of
pre-test HIV counseling, and thus facilitates the consent
process for healthcare providers who lack specific training
regarding the performance of HIV counseling. We also
have encouraged nurse-based rather than physician-based
pre-test counseling [40]. Nurses perform many educa-
tional, health promotion, and disease prevention tasks as
well as physicians [41]. Organizational changes that shift
responsibilities from physicians to other personnel, most
often nurses, are effective in improving preventive care.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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Sample Audit/Feedback letter Figure 2
Sample Audit/Feedback letter. The original report identifies the station and sub-stations by name rather than as "Station A" and 
sub-stations 1–11. The data provided in this letter indicate the number of persons with identified HIV risk factors who were 
tested for HIV or who were indicated to have refused HIV testing. No patient had previously been tested for HIV. These 
results, which represent incident HIV testing and refusal rates, differ from the data given in the results section that indicates the 
cumulative proportion of patients with identified HIV risk factors who had ever been tested. Achievement of 100% on the Y 
axis would indicate that all at-risk patients were offered HIV testing as denoted by records indicating that HIV testing was per-
formed or refused by the patient.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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Moreover, we have encouraged providers to use a stream-
lined HIV counseling process that covers all the required
elements of HIV pre-test counseling and reduces the time
of pre-test counseling to 2–3 instead of 10–15 minutes,
with some counseling lasting as long as 35 minutes [42].
Similarly, we have reduced the logistical challenges of
post-test HIV counseling [16]. Given the gravity of the
information, post-test counseling for persons with new
positive HIV test results strongly warrants face-to-face
counseling. In contrast, we have alerted providers that for
patients with a negative result, post-test counseling can be
very brief and can be done via the telephone [43]. To
ensure compliance with post-test counseling require-
ments, we have distributed sample scripts for transmitting
the results of the test.
In addition to being theory-informed, these interventions
are informed by empirical evidence provided by studies in
urgent care clinics, emergency departments, and STD (sex-
ually transmitted disease) clinics that show increased test-
ing rates and patient receipt of test results after
implementation of structural changes, such as improved
staff training in pre- and post-testing screening, introduc-
tion of streamlined counseling, and substitution of tele-
phonic post-test counseling in place of a required return
visit for face-to-face notification [43].
Implementation
The intervention program is being put in place for one
year in the primary care clinics of stations A and B in VISN
22. The three remaining stations in VISN 22 (stations C, D
and E) served as controls. These facilities each provide care
to 37,000 – 80,000 veterans per year. Facilities were
assigned to the active or control arms by convenience. All
facilities, except for one of the controls, consisted of an
inpatient center plus one or more geographically dis-
persed sub-stations in which primary care and specialty
services, including mental health and substance abuse
treatment programs, were provided by academic staff phy-
sicians, post-graduate medical trainees, and mid-level
providers. In addition, these facilities also provided pri-
mary care in other sub-stations staffed solely by non-aca-
demic physicians and mid-level providers. At the
remaining control facility, care was provided only in out-
patient sub-stations by providers who generally did not
have an academic affiliation.
The decision support aspects of the intervention and pol-
icies regarding performance of HIV consenting and coun-
seling have been implemented at all sub-stations and all
clinics at the active facilities. However, the provider activa-
tion component of the program (i.e., academic-detailing
and social marketing) has been fully implemented only in
the primary care clinics at the two largest sub-stations at
Facility A (out of a total of 11 sub-stations) and at the two
largest sub-stations at Facility B (out of a total of 6 sub-sta-
tions); these sub-stations account for 46% and 69% of
patients seen in primary care clinics at Facilities A and B,
respectively. The other, smaller and geographically distant
sub-stations differ in that e-mail and telephonic outreach
largely replace personal outreach to promote academic
detailing; all other tools (i.e., audit/feedback, provision of
printed materials such as e-mail communications, pocket
cards, posters and flyers, and removal of organizational
barriers) are the same at all stations. The audit feedback
program is directed at all providers in every primary care
clinic.
Evaluation plan
The primary endpoints of this step 4/phase 1 two-station
pilot project are the effect of the implementation program
on the rates of resolution of the HIV clinical reminder and
of HIV testing in patients with identified HIV risk factors.
A multi-level, logistic regression analysis of the HIV test-
ing rate will be done to adjust for the covariates at patient,
provider, and sub-station levels – and for clustering.
We have obtained information regarding all inpatient and
outpatient patient encounters within VISN 22 from a pre-
established network database. For patients seen in outpa-
tient clinics before and/or after the intervention, we
obtained relevant laboratory tests, diagnosis codes, and
health factors to determine if they were at increased risk
for HIV.
Data regarding non-VA HIV testing, refusal of HIV testing,
and incompetence for HIV testing were extracted from the
standardized VA clinical reminder software package.
Patients were defined as having been tested for HIV if
there was documentation of HIV testing done within the
VA healthcare system. Veterans were defined as having
been evaluated for HIV if there was electronic documenta-
tion of prior HIV testing within the VA or elsewhere,
patient's refusal to be tested, or patient's incompetence to
consent for testing. Information regarding prior HIV test-
ing within the VA was obtained through the VA electronic
laboratory records, whereas information regarding out-
side testing, test refusal, and incompetence to consent was
collected through responses to the HIV testing clinical
reminder.
In addition to the data abstracted from the VISN 22 data-
base, we also obtained a list of primary care providers clas-
sified into provider types (senior staff physicians, mid-
level providers, physician assistants, and post-graduate
medical trainees) from the primary care administration
staff at Facilities A and B. The data on provider types were
used to compare HIV testing and evaluation performance
across different types of primary care providers.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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As previously noted, we fully implemented the provider
activation module only at the largest sub-stations at the
intervention stations. This design allows us to assess
whether this module, which is the most labor intensive
component of our implementation strategy, independ-
ently contributes to improvement in the rates of HIV
screening and testing. In addition, we are conducting
formative evaluations to further refine our program and
assess the organizational factors that determine the gener-
alizability [38]. The overall aim is to better understand the
influences that have an impact on the success of the
implementation program by identifying contextually rele-
vant factors (i.e., facilitators and barriers) and assessing
the degree to which behaviors that led to improved testing
performance become part of routine practice [38]. Semi-
structured interviews with key informants will provide
qualitative data regarding the effectiveness of the mode
used for providing audit/feedback, the usefulness and usa-
bility of the testing reminder, and the efficiency of the
consenting/counseling process. Interview questions will
employ rapid ethnographic assessment methods to
explore the ecological context of HIV testing [44].
To assess the degree to which behaviors leading to
improved testing performance are institutionalized (i.e.,
become embedded in standard operating procedures),
leading clinicians and administrators at each sub-station
will complete a Level of Institutionalization survey. The
instrument measures four sub-systems that support rou-
tine use of an innovation: production, where it must be
integrated with other routine clinical services; mainte-
nance, where employees must support it; supportive, where
it must have a stable source of funding; and managerial,
where it must be assigned to a specific service, staff must
have written job descriptions, and performance is
required to be measured and reported [45].
Finally, we are generating a comprehensive analysis of the
workload and implementation costs of HIV screening and
testing programs, using Business Case Modeling, a
method for constructing data-driven models that forecast
costs under varying specified conditions that support
managerial or technical decision-making. This is war-
ranted as the models of the cost-effectiveness of HIV
screening do not address the upfront costs of implement-
ing screening programs across differing clinic settings
[2,3,46].
Results
Preliminary unadjusted data show an increase in the
cumulative rate of reminder resolution (i.e., rate at which
the reminder was appropriate addressed) from 22% to
64% at Station A and from 33% to 70% at Station B dur-
ing the first seven months of this project. Although the
amount of salutary change varied across the geographi-
cally dispersed sub-stations of the two study stations, all
sub-stations showed substantial increases in the rate of
resolution of the HIV Testing Clinical Reminder. In con-
trast, no change in the reminder resolution rate was seen
at the other VISN 22 stations where the intervention was
not undertaken. Actual monthly rates of HIV testing (as
opposed to other means of resolving the HIV Testing Clin-
ical Reminder) increased 3–5 fold. In contrast, no change
in HIV testing rates was seen in the control stations. As
compared to at-risk patients seen at the control facilities,
at-risk patients at the intervention facilities were more
likely to be African American or to have a history of either
illicit drug use or homelessness. Otherwise there were no
significant differences among the demographics and risk
factors for HIV risk factors of veterans who received care at
the intervention versus the control facilities.
Of note, we found an unexpected high variation in the
ratio of HIV test refusals to test performances with some
sub-stations recording 10–20 times as many refusals as
actual tests, whereas other sites had fewer refusals than
tests. These results are at odds with studies that show
higher rates of acceptance of HIV testing [23]. Our prelim-
inary analyses suggest that some providers take more care
than others in terms of informing patients of the benefits
of knowing their HIV status. Furthermore, the rates of
resolving the HIV clinical reminder and the ratio of HIV
test refusal to performance appear to differ substantially
among provider types (i.e., senior staff physicians vs. mid-
level practitioner vs. post-graduate medical trainee), with
trainees performing far less well than other providers.
Thus far, our preliminary formative evaluation also indi-
cates that further work needs to be done to address sta-
tion-specific barriers to HIV testing. Particular areas of
concern include the development of procedures to
address variances in the adoption of new technologies,
such as the use of new, electronic paperless versions of the
VA HIV consent form. Other important station-to-station
differences involve workflow patterns. For example, sta-
tion B routinely utilizes more nursing personnel for nor-
mal clinic routines. Therefore, their intake nurses were
expected to share consenting and counseling responsibil-
ities to promote efficient processing of at-risk patients.
The process of addressing reminders at station A, on the
other hand, is more physician-driven and requires target-
ing activation strategies to their different role and skill set.
Our step 4/phase 1 two-station project also has allowed us
to identify aspects of the HIV testing clinical reminder that
lead to provider dissatisfaction. In particular, providers
would like the reminder to clearly indicate what specific
factor(s) triggered the HIV Testing Clinical Reminder, so
that they can better counsel patients as to why HIV testing
is relevant to the veteran's circumstances. Providers also
have expressed a strong belief that homelessness, per se, isImplementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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not a substantial risk factor for HIV infection, and that
HIV testing may not be relevant to persons with a limited
life expectancy. Finally, providers perceive the layout of
the reminder to be unduly complicated.
Discussion
This project has greatly benefited from practical guidance
and consistent support of the VA QUERI program. For
example, a step 3 study by Owens et al., showing that
fewer than half of at-risk VA patients were tested for HIV,
formed an important part of the basis of our rationale to
proceed to step 4 [11]. These results were confirmed by
further evaluations supported by core funding provided
through the QUERI program. Moreover, the QUERI proc-
ess guided our analysis of the importance of improving VA
HIV testing rates, our assessment of the gaps in care, and
the development of a multi-faceted project with broad-
based institutional support to close this quality gap.
Although the full analysis of our step 4/phase 1 two-sta-
tion pilot project results is pending, and efforts to gauge
the sustainability of our project are only just beginning,
release of our preliminary results [47] has attracted con-
siderable attention from other VA facilities, some of which
are undertaking similar efforts to implement the elec-
tronic HIV Testing Clinical Reminder. The results of such
implementations, which are being done without formal
provider activation components, are not yet available.
Specific issues of particular importance to our implemen-
tation program are discussed below.
Importance of leadership and team buy-in
The successful implementation of this project and the
favorable preliminary results could not have been
achieved without support at multiple administrative and
clinical levels. The VA PHSHG provided invaluable sup-
port by promoting HIV testing within the VA, and by
developing the HIV Testing Clinical Reminder. Their
backing facilitated our ability to get the support of VISN
22 network leadership. In turn, this enabled us to elicit
support for the institutionalization of the reminder,
organizational changes, and implementation of the pro-
vider activation program at the individual stations where
the step 4/phase 1 two-station pilot project was launched,
and, subsequently to get the buy-in of individual primary
team leaders. Ultimately, provider support is crucial.
Acquiring this support required us to address issues of
concern to providers, most notably facility-specific barri-
ers to HIV testing, variances in the prevalence of HIV risk
factors, issues related to the use of the reminder, and fac-
tors that contribute to variances in actual HIV testing ver-
sus refusal of HIV testing.
Station-specific barriers
Despite being a single healthcare system, there are sub-
stantial variances in local policies, processes, and institu-
tional culture within the VA that must be addressed by
station-specific customization of implementation
projects. For example, differences between the processes
of HIV consenting and counseling in stations A and B
have required separate activation/education sessions with
nursing staff regarding mandated requirements of the
counseling/consenting process and the legal boundaries
of their scope of practice. We also have found that further
variations in training needs arise from differences in the
mixtures of providers, such as the degree to which patient
care is delivered by mid-level providers, post-graduate
medical trainees, part-time physicians, contract employ-
ees, and full-time staff physicians. Furthermore, one sta-
tion only allowed trained HIV counselors, who were
positioned in key clinics and sub-stations, to order HIV
tests or to perform pre- or post-test counseling. We needed
to work with key stakeholders to change these policies. In
addition, the rate of implementation of new technology
varies. Thus, while electronic consent for HIV testing is
available [48], acceptance of paperless consent requires
concomitant local policy changes. Similar issues pertain
to the implementation of rapid-testing for HIV infection –
a procedure that has excellent patient acceptance in the VA
[12].
Variations in the prevalence of HIV risk factors
Although individual providers generally have a panel size
that is normalized to the time they spend in clinic, the
proportion of veterans with HIV risk factors can vary dra-
matically. For example, a much higher proportion of
patients trigger the HIV Testing Clinical Reminder in clin-
ics that care for large numbers of veterans with drug use
histories or hepatitis C infection. Providers in such clinics
warrant attention to ensure that they do not feel over-
whelmed by the burden of work precipitated by respond-
ing to these reminders.
Issues related to use of the reminder
As per the FITT model, reminders require customization
to the needs of providers [34]. We have found that provid-
ers benefit from having ready access to the specific fac-
tor(s) that trigger the HIV Testing Clinical Reminder for an
individual patient. In addition, it is important that the fac-
tors that trigger the Reminder be as closely linked to actual
risks of HIV infection as possible. In this regard, we have
found that the triggers for a diagnosis of homelessness are
sufficiently non-specific (i.e., loss of housing for a few
days) as not to warrant inclusion in the reminder. Simi-
larly, the process triggered by the Reminder needs to be of
potential benefit to the patient. Thus exclusion of persons
with a very limited life expectancy is appropriate. Based
on these findings, we are adopting a revision of the
Reminder that addresses these issues.Implementation Science 2008, 3:16 http://www.implementationscience.com/content/3/1/16
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HIV Test ordering versus HIV test refusal
The substation-specific variances in the ratio of HIV test
orders to HIV test refusal was an unexpected finding. In
response we are seeking to better understand the determi-
nants of these behaviors. We anticipate that these will
include provider comfort with HIV testing and site-spe-
cific barriers to HIV testing. We will also determine
whether particular demographic factors, HIV risk factors
or physician factors, are associated with patient refusal of
HIV testing. Based on our findings, we will design a
broader campaign of provider activation, such as remind-
ing providers of patient acceptance of HIV testing [23] and
delivery system changes to alleviate this discrepancy.
In summary, the strengths of our study include a quasi-
experimental design that permits comparison of the effect
of the implementation program on changes on HIV test-
ing and evaluation rates – before and after the program is
active and with control stations. This program relies heav-
ily on the built-in quality improvement infrastructure in
the VA, including the electronic medical record, clinical
reminder software, and familiarity with performance
measurements. Although unique aspects of the VA infra-
structure will make it more difficult to generalize intro-
duction of our process to healthcare systems that do not
have these tools, such systems are becoming increasing
common. Other limitations of our current findings
include our incomplete qualitative process (or formative)
evaluation to better understand the influences that impact
the success of the program. In ongoing work we hope to
identify contextually relevant factors (i.e., facilitators and
barriers) and assess the degree that behaviors leading to
improved testing performance become part of routine
practice [38]. Areas of particular interest will be evaluating
the contribution of nurse-based vs. physician-based HIV
testing and evaluation, as well as the role of intensive pro-
vider activation, as this is the most costly and time con-
suming activity. Finally, although the overall cost-
effectiveness of HIV screening is not in doubt, these mod-
els do not address variations in the complexity of screen-
ing programs across differing clinic settings, nor the costs
of implementing a screening program [2,3,46].
Next steps
After completing our 12-month QUERI step 4/phase 1,
two-station (site) pilot project, we will extend our work by
performing a QUERI step 4/phase 2, small-scale, multi-
site evaluation at all five VISN 22 stations. This will allow
us to conduct a formal, multi-site formative and analytical
evaluation, determine the sustainability of our project in
our initial two-stations, determine the institutionalization
of behaviors by our two-station pilot, and further refine
and evaluate our implementation program.
If the phase 2 results are favorable, we plan to study the
refined program in multiple geographic regions (QUERI
step 4/phase 3), prior to a national roll-out of the program
(QUERI step4/phase 4). We anticipate that with any wide-
spread roll-out there will still be a need for the receiving
facility to adapt/contextualize/customize the implemen-
tation program to maximize the likelihood of adoption.
Finally, QUERI steps 5 and 6 call for documentation that
best practices improve outcomes and that outcomes are
associated with improved health-related quality of life.
Therefore, of ultimate concern is whether increased rates
of HIV screening and testing actually increase the rates of
early HIV diagnosis, decrease HIV transmission and dis-
ease progression, and improve quality of life for HIV-
infected and uninfected persons.
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